Dr Giuseppe Mazza

Giuseppe Mazza is a Principal Investigator at the UCL Institute for Liver and Digestive Health. He joined the UCL Division of Medicine in 2013 and received his PhD in Tissue Engineering and Organ Regeneration. Dr Mazza pioneered the decellularisation procedure for whole human liver as well as the development of novel decellularisation procedures for small scale tissue scaffold development. He is currently responsible for Tissue Engineering and Regenerative Medicine at UCL, ILDH. He has been Director of R&D at Promethera Biosciences from 2015 to 2017 and he is currently the Co-Founder and CEO at Engitix Ltd a UCL spin-out company.